Literature DB >> 25495517

The potential of targeting NMDA receptors outside the CNS.

Milica Bozic1, José M Valdivielso.   

Abstract

INTRODUCTION: NMDA receptor (NMDAR) is an ionotropic glutamate receptor with a high permeability to calcium and a unique feature of controlling numerous calcium-dependent processes. Apart from being widely distributed in the CNS, the presence of NMDAR and its potential significance in a variety of non-neuronal cells and tissues has become an interesting research topic. AREAS COVERED: The current review summarizes prevailing knowledge on the role of NMDARs in the kidney, bone and parathyroid gland, three main organs responsible for calcium homeostasis, as well as in the heart, an organ whose function is highly dependable on balanced intracellular calcium concentrations. The review also examines studies that have advanced our understanding of the therapeutic potential of NMDAR agonists and antagonists in renal, cardiovascular and bone pathologies. EXPERT OPINION: NMDARs have a preeminent role in many physiological and pathological processes outside the CNS. In certain organs and/or disease conditions, activating the NMDAR leads to beneficial effects for the target organ, whereas in other diseases cell signaling downstream of NMDAR activation can exacerbate their pathology. Therefore, targeting NMDARs therapeutically is rather intricate work, and surely requires more extensive investigation in order to properly tune up the diverse NMDAR's actions translating them into beneficial cellular responses.

Entities:  

Keywords:  NMDA; bone; calcium; cardiomyocytes; heart; kidney; osteoblasts; osteoclasts; parathyroid gland; podocyte; proximal tubule

Mesh:

Substances:

Year:  2014        PMID: 25495517     DOI: 10.1517/14728222.2014.983900

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  21 in total

1.  The dual-functional memantine nitrate MN-08 alleviates cerebral vasospasm and brain injury in experimental subarachnoid haemorrhage models.

Authors:  Fangcheng Luo; Liangmiao Wu; Zhixiang Zhang; Zeyu Zhu; Zheng Liu; Baojian Guo; Ning Li; Jun Ju; Qiang Zhou; Shupeng Li; Xifei Yang; Shinghung Mak; Yifan Han; Yewei Sun; Yuqiang Wang; Gaoxiao Zhang; Zaijun Zhang
Journal:  Br J Pharmacol       Date:  2019-07-31       Impact factor: 8.739

2.  Role of Cellular Metabolism in Pulmonary Diseases.

Authors:  David Wu; Parker S Woods; Heng T Duong; Gökhan M Mutlu
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

3.  The effects of verapamil and its combinations with glutamate and glycine on cardiodynamics, coronary flow and oxidative stress in isolated rat heart.

Authors:  Isidora Stojic; Ivan Srejovic; Vladimir Zivkovic; Nevena Jeremic; Marko Djuric; Ana Stevanovic; Tamara Milanovic; Dragan Djuric; Vladimir Jakovljevic
Journal:  J Physiol Biochem       Date:  2016-11-03       Impact factor: 4.158

Review 4.  Expanding Role of NMDA Receptor Antagonists in the Management of Pain.

Authors:  Denise Kreutzwiser; Qutaiba A Tawfic
Journal:  CNS Drugs       Date:  2019-04       Impact factor: 5.749

5.  Estradiol mitigates ischemia reperfusion-induced acute renal failure through NMDA receptor antagonism in rats.

Authors:  Amrit Pal Singh; Nirmal Singh; Preet Mohinder Singh Bedi
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

6.  Pioglitazone ameliorates renal ischemia reperfusion injury through NMDA receptor antagonism in rats.

Authors:  Amrit Pal Singh; Nirmal Singh; Preet Mohinder Singh Bedi
Journal:  Mol Cell Biochem       Date:  2016-05-20       Impact factor: 3.396

7.  Neurotransmitter signaling pathways required for normal development in Xenopus laevis embryos: a pharmacological survey screen.

Authors:  Kelly G Sullivan; Michael Levin
Journal:  J Anat       Date:  2016-04-07       Impact factor: 2.610

Review 8.  Back to the Future: Evaluation of the Role of Glutamate in Bone Cells.

Authors:  Larry J Suva; Dana Gaddy
Journal:  Calcif Tissue Int       Date:  2016-04-09       Impact factor: 4.333

9.  Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.

Authors:  Izabela Zakrocka; Katarzyna M Targowska-Duda; Artur Wnorowski; Tomasz Kocki; Krzysztof Jóźwiak; Waldemar A Turski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-29       Impact factor: 3.000

Review 10.  N-Methyl-D-Aspartate Receptor Signaling and Function in Cardiovascular Tissues.

Authors:  Marie A McGee; Abdel A Abdel-Rahman
Journal:  J Cardiovasc Pharmacol       Date:  2016-08       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.